2022
DOI: 10.1007/s00221-022-06481-w
|View full text |Cite
|
Sign up to set email alerts
|

CUX2 prevents the malignant progression of gliomas by enhancing ADCY1 transcription

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…Previous studies have not found that ADCY1 is associated with epilepsy. ADCY1 regulate distinct aspects of synaptic and cognitive exibility, glioma development and Fragile X syndrome [40][41][42]. NeuroD6-mediated transcriptional regulatory pathways linking neuronal differentiation to survival [43].…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have not found that ADCY1 is associated with epilepsy. ADCY1 regulate distinct aspects of synaptic and cognitive exibility, glioma development and Fragile X syndrome [40][41][42]. NeuroD6-mediated transcriptional regulatory pathways linking neuronal differentiation to survival [43].…”
Section: Discussionmentioning
confidence: 99%
“…SLC6A1 was up-regulated in colorectal cancer and can be used as an independent marker for colorectal cancer prognosis ( 29 ). Adenylyl cyclase 1 (ADCY1) overexpression inhibited glioma cell invasion, migration, and proliferation ( 30 ). Low expression of ADCY1 was related to pancreatic adenocarcinoma patients’ overall survival, and it was an independent risk factor for pancreatic adenocarcinoma ( 31 ).…”
Section: Discussionmentioning
confidence: 99%